Full Press Release Details
Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)
Limited (Scrip Code: 500124)
York Stock Exchange Inc. (Stock Code: RDY)
IFSC Ltd (Stock Code: DRREDDY)
Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - clarification
on reported news article published in electronic media, https://www.cnbctv18.com/
is in reference to Regulation 30(11) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing
Regulations") regarding a news article published in electronic media https://www.cnbctv18.com
on February 17, 2024, with the heading "Novartis AG conducting strategic review of India-listed
business, no decision on outcome yet: Novartis India".
said news article, inter alia, talks about "Dr Reddy's is likely in a race to acquire Novartis AG's stake in Novartis India.
The sources said Dr Reddy's plans to acquire the domestic-focused portfolio and may offer controlling premium". In this regard,
please note that the Company does not comment on market speculations and there is currently no such event or information which requires
a disclosure under Regulation 30 of the SEBI Listing Regulations.
compliance with Regulation 30 of the SEBI Listing Regulations, the Company makes prompt disclosures, as and when any event or information
is considered material or warrants such disclosure under the said Regulations.
is for your information.
Dr. Reddy's Laboratories Limited
Secretary, Compliance Officer and Head-CSR